Johnson, Professor Peter

MA MD FRCP

Speciality

Medical Oncology

Sub-speciality

Haemato-oncology

Training and Education

Cambridge University and St Thomas's Medical School;  ICRF Clinical Research Fellow and Registrar in Medical Oncology, St Bartholomew's Hospital, London; ICRF Senior Lecturer in Medical Oncology, St James' University Hospital, Leeds.

Experience

Professor johnson has worked for Southampton University Hospitals Trust since August 1998. 

Accreditation in Medical Oncology in 1994. Extensive experience in management of malignant lymphoma including high dose therapy and stem cell transplantation.

Key achievements

Chief Clinician at Cancer Research UK. Chair of NCRI Lymphoma Clinical Studies Group. Chief investigator in multiple clinical trials in lymphoma and immunotherapy. Director of CR UK Centre in Southampton.  Editorial Board, NICE Guidelines on Improving Outcomes in Haematologic Cancers.

Key awards and prizes

Sir Lionel Whitby Medal and Ralph Noble Prize for MD.

Research

P.W.M. Johnson, J.A. Radford , M.H. Cullen, et al.   Comparison of ABVD and Alternating or Hybrid multi-drug regimens for the treatment of advanced Hodgkin’s Lymphoma: Results of the UK Lymphoma Group LY09 Trial. Journal of Clinical Oncology, 2005. 23:9208-9218 

A. Hagenbeek, O. Gadeberg, P. Johnson,et al.   First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase I/II trial
Blood, 2008 111:5486-95.

T. Geldart, M. Glennie, P. Johnson.  Monoclonal antibodies and therapy in Cellular and Molecular biology of Cancer, 4th Edition.  Oxford University Press, Oxford 2005.